Trevi Therapeutics, Inc. Quarterly Depreciation in USD from Q1 2018 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Trevi Therapeutics, Inc. annual/quarterly Depreciation history and growth rate from Q1 2018 to Q1 2022.
  • Trevi Therapeutics, Inc. Depreciation for the quarter ending March 31, 2022 was $11K, a 15.4% decline year-over-year.
  • Trevi Therapeutics, Inc. annual Depreciation for 2023 was $81K, a 88.4% increase from 2022.
  • Trevi Therapeutics, Inc. annual Depreciation for 2022 was $43K, a 14% decline from 2021.
  • Trevi Therapeutics, Inc. annual Depreciation for 2021 was $50K, a 6.38% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $11K -$2K -15.4% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q1 2021 $13K +$3K +30% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $10K +$1K +11.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q1 2019 $9K +$7K +350% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q1 2018 $2K Jan 1, 2018 Mar 31, 2018 10-Q 2019-06-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.